- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04022122
Impact of Socio Economic Limitations on Health Outcomes in Patients With Recent Admission for Heart Failure (SELENE)
Impact of Socio Economic Limitations on hEalth Outcomes in Patients With Complex and Advanced Chronic Cardiovascular Conditions in High-standard iNtegrated Care Environements (SELENE Study)
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The SELENE Study (Impact of SocioEconomic Limitations on health outcomes in patients with complex and advanced chronic cardiovascular conditions in high-standard iNtegrated care Environments) is an observational, cohort, prospective, multicenter study of consecutive patients treated in a comprehensive heart failure (HF) management program, and hospitalized by decompensated HF in our healthcare area; aimed at evaluating the impact of socioeconomic level on the effectiveness of a comprehensive multidisciplinary program of transitional care to patients with HF, both globally and in the various profiles of chronic management of HF.
In this study we aim to assess the impact of the socio-economic level on the effectiveness of a comprehensive multidisciplinary program of transitional care for chronic heart failure patients (primary objective); to analyze this specifically in the various chronic management profiles of HF patients and to study the associations between NSE and other psychosocial aspects (secondary objective).
All patients will have a detailed assessment by a social worker of a battery of psychosocial and functional variables, including educational level, functional status, cognitive status, family support, or the existence of a primary caregiver and an assessment of purchasing power through the value of monthly income. The events that will be analyzed, both for the primary objective of the study and the secondary objective related to the different follow-up profiles, will be re-admissions at 30 days (primary event), and mortality at 30, 90 and 180 days, as well as hospital admission at 90 days and 6 months (secondary events). Using the "median" income group as a reference, comparisons will be made between the rates of these events among the different groups.
The researchers hypothesize that the socioeconomic level has an impact on clinical events of HF patients so that the effectiveness of comprehensive care programs for HF is attenuated in patients with low socioeconomic level.
Study Type
Enrollment (Actual)
Contacts and Locations
Study Contact
- Name: Josep Comín Colet, MD,PhD
- Phone Number: +34 93 260 7078
- Email: jcomin@bellvitgehospital.cat
Study Contact Backup
- Name: Sergi Yun Viladomat, MD
- Phone Number: +34 93 260 7078
- Email: sergi.yun@bellvitgehospital.cat
Study Locations
-
-
Barcelona
-
L'Hospitalet de Llobregat, Barcelona, Spain, 08907
- University Hospital Bellvitge
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- Age ≥ 18 years old.
- Patients discharged from a heart failure hospitalization within 30 days of enrollment into the study or in the process of discharge planning.
- Heart Failure diagnosis according to European Society of Cardiology (ESC) criteria.
- Written informed consent must be obtained before any assessment is performed.
- Patients receiving oral standard medication for chronic heart failure (CHF).
- All patients will be eligible regardless the level of left ventricular ejection fraction (LVEF).
Exclusion Criteria:
- Age<18 years old.
- Death before hospital discharge.
- The patient is unable or unwilling to give the informed consent to participate.
- Unstable patients with signs of fluid overload or low cardiac output.
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Heart Failure patients
The study does not imply any specific therapeutic intervention, and will not imply any change in the management of the participating patients, who will follow the usual clinical controls and will receive the medical and invasive treatments usually provided to patients with HF in our health area; as well as the different modalities of specific health education for this disease.
At the time of hospital discharge, patients will be handled according to the usual protocols of the center established for outpatient follow-up of HF patients.
|
Standard follow-up involves hospital and primary care for HF patients.
In this context, physicians and nurses experienced in the care and management of HF direct care.
HF care is based on 1) active detection of newly admitted HF patients, 2) planned educational interventions to improve self-care, 3) completion of a comprehensive psychosocial assessment of patients and caregivers, 4) discharge planning and home transition coordination involving the hospital HF team and Primary Care teams, 5) structured and planned evidence-based follow-up shortly after discharge from hospital.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Occurrence of cardiovascular death or non-fatal heart failure events
Time Frame: Six months after inclusion of the patient.
|
Occurrence of cardiovascular death or non-fatal heart failure events (time to first event) during a follow-up period of 6 months.
Non-fatal heart failure event is defined as a new episode of worsening of symptoms and signs consistent with acute decompensated HF requiring intravenous decongestive therapy (e.g.
diuretics) either on an outpatient basis (day-case HF hospital) or in the emergency department (<24 hours) or requiring unplanned hospital admission (>24 hours) or complicating the course of a non-cardiovascular admission.
|
Six months after inclusion of the patient.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Readmission (all-cause, HF and cardiovascular) rate and total number.
Time Frame: Six months after inclusion of the patient.
|
Comparison of the different socioeconomic levels at the end of follow-up.
|
Six months after inclusion of the patient.
|
Days in hospital (all-cause, HF and cardiovascular).
Time Frame: Six months after inclusion of the patient.
|
Comparison of the different socioeconomic levels at the end of follow-up.
|
Six months after inclusion of the patient.
|
Rate of emergency visits.
Time Frame: Six months after inclusion of the patient.
|
Comparison of the different socioeconomic levels at the end of follow-up.
|
Six months after inclusion of the patient.
|
Rate of non-fatal HF events.
Time Frame: Six months after inclusion of the patient.
|
Comparison of the different socioeconomic levels at the end of follow-up.
|
Six months after inclusion of the patient.
|
Mortality for any cause and cardiovascular mortality.
Time Frame: Six months after inclusion of the patient.
|
Comparison of the different socioeconomic levels at the end of follow-up.
|
Six months after inclusion of the patient.
|
Change of self-care using a validated scale (European Heart Failure Self-Care Behavior Scale)
Time Frame: Six months after inclusion of the patient.
|
Comparison of the different socioeconomic levels at the end of follow-up.
|
Six months after inclusion of the patient.
|
Change of quality of life using a validated questionnaire (EUROQOL - 5D).
Time Frame: Six months after inclusion of the patient.
|
Comparison of the different socioeconomic levels at the end of follow-up.
|
Six months after inclusion of the patient.
|
Patient satisfaction using a Likert-type scale.
Time Frame: Six months after inclusion of the patient.
|
Comparison of the different socioeconomic levels at the end of follow-up.
|
Six months after inclusion of the patient.
|
Collaborators and Investigators
Collaborators
Investigators
- Principal Investigator: Josep Comín Colet, MD,PhD, Head of the Cardiology Department and the Community Heart Failure Unit. MD, PhD
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Estimated)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- IDIBELL-2019/PR157/19
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Heart Failure
-
Tufts Medical CenterMetro West Medical CenterCompletedCongestive Heart Failure | Diastolic Heart Failure | Systolic Heart FailureUnited States
-
Abbott Medical DevicesCompletedHeart Failure | Heart Failure, Diastolic | Heart Failure, Systolic | Heart Failure NYHA Class II | Heart Failure NYHA Class III | Heart Failure With Reduced Ejection Fraction | Heart Failure NYHA Class IV | Heart Failure With Normal Ejection Fraction | Heart Failure; With Decompensation | Heart Failure...United States, Canada
-
Manipal UniversityUnknownHeart Failure | Decompensated Heart Failure | Acute Heart Failure | Diastolic Heart Failure | Systolic Heart FailureIndia
-
University Hospital, MontpellierCompletedHeart Failure | Diastolic Heart Failure | Systolic Heart Failure Stage CFrance
-
VA Eastern Colorado Health Care SystemNational Institute on Aging (NIA)CompletedHeart Failure | Heart Failure, Diastolic | Heart Failure, Systolic | Heart Failure With Reduced Ejection Fraction | Heart Failure With Preserved Ejection Fraction | Heart Failure; With Decompensation | Heart Failure,Congestive | Heart Failure AcuteUnited States
-
Wake Forest UniversityCompletedHeart Failure, Congestive | Heart Failure With Preserved Ejection Fraction
-
Lancaster General HospitalLouise von Hess Medical Research InstituteEnrolling by invitationDiastolic Heart FailureUnited States
-
Giresun UniversityIstanbul University - Cerrahpasa (IUC)RecruitingHeart Failure | Diastolic Heart Failure | Systolic Heart FailureTurkey
-
Wake Forest UniversityNational Institute on Aging (NIA)CompletedHeart Failure, Congestive | Diastolic Heart FailureUnited States
-
US Department of Veterans AffairsCompleted
Clinical Trials on Usual Care follow-up in a heart failure program.
-
University of Colorado, DenverNational Heart, Lung, and Blood Institute (NHLBI)CompletedCongestive Heart Failure | Cardiac FailureUnited States
-
University of Sao PauloCompletedCoronary Artery Disease | Percutaneous Coronary InterventionBrazil
-
Johns Hopkins UniversityNational Institute of Nursing Research (NINR)CompletedHeart FailureUnited States
-
Norwegian University of Science and TechnologySt. Olavs Hospital; Helse Nord-Trøndelag HFCompletedMyocardial Infarction | Cardiovascular Diseases | Angina (Stable)Norway
-
University Hospital, LilleMinistry of Health, FranceRecruitingDepression, Postpartum | Mother-child Relations | Child Behavior DisordersFrance
-
Queen's University, BelfastBelfast Health and Social Care Trust; Southern Health and Social Care TrustWithdrawnCataract | Age-related Cataract
-
University of Alabama at BirminghamUS Department of Veterans AffairsCompletedHeart FailureUnited States
-
Centre Hospitalier Universitaire de Saint EtienneRecruiting
-
Hospital Universitario ArabaLinde Health Care; Spain:Health Department. Basque Government.Completed
-
Hospital Moinhos de VentoNot yet recruiting